Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
Joseph J. Caumanns(University Medical Center Groningen), Steven de Jong(University Medical Center Groningen)
Cited by 58
Related Papers
MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
|The Journal of Pathology|2019|163
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines
|British Journal of Cancer|2003|62
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
|Clinical Cancer Research|2018|52
ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
|Oncotarget|2017|31
‘Big’-Insulin-Like Growth Factor–II Signaling Is an Autocrine Survival Pathway in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2012|18